21st Apr 2021 12:21
UDG Healthcare plc
Notice of Interim Results
UDG Healthcare plc (LSE: UDG), a leading international healthcare services provider, will be announcing its half year results for the six months ended 31 March 2021 on the morning of Tuesday 18 May 2021.
Brendan McAtamney, Chief Executive Officer, Nigel Clerkin, Chief Financial Officer, and Ryan Quigley, Chief Operating Officer will host a virtual presentation for analysts and investors to discuss the company's half year results and provide an update on each of the Group's divisions, followed by a Q&A.
Date: | Tuesday 18 May 2021
|
Time:
| The video webcast will commence at 8.30am, and be followed by a live audio Q&A. Please dial-in at 8.15am.
|
Webcast registration link:
| https://secure.emincote.com/client/udghealthcare/udg008 |
Conference call registration link: | https://secure.emincote.com/client/udghealthcare/udg008/vip_connect
|
Please note: If you wish to ask a question during the live Q&A, please dial into the conference call, as participants on the webcast will be in listen-only mode and therefore unable to ask questions.
For further information, please contact:
UDG Healthcare plc Keith Byrne |
|
Head of Investor Relations, Strategy & Corporate Communications |
|
Tel: +353-1-468-9000 |
|
|
|
Powerscourt |
|
Lisa Kavanagh / Jack Hickey / Eavan Gannon / Ella Morris |
|
| |
|
|
About UDG Healthcare plc:
UDG Healthcare plc (LON: UDG) is a FTSE 250 global leader in healthcare advisory, marketing, communications, strategic engagement, patient solutions and packaging services. UDG employs 9,000 people across operations in 29 countries, delivering services in over 50 countries.
Operating across two divisions, Ashfield and Sharp, UDG provides outsourced services to over 300 healthcare companies from large pharmaceutical to small biotech companies.
Ashfield is a global integrated healthcare services partner, operating across three business areas: Ashfield Advisory, Ashfield Engage and Ashfield Health. The division enables its healthcare clients to bring their products to market, supporting them through every stage of the product lifecycle, to improve the lives of patients. Ashfield offers a breadth of services, developed organically and through acquisition, across strategic consulting, benchmarking, commercialisation, customer engagement, events, marketing and communications.
Sharp is a global leader in contract commercial packaging, clinical, manufacturing and technology services for the pharmaceutical and biotechnology industries, operating from eight state-of-the-art facilities in the US and Europe.
For more information, please go to: www.udghealthcare.com
Related Shares:
UDG.L